Enlivex (ENLV) FCF Payout Ratio (2013 - 2016)
Enlivex (ENLV) posted quarterly FCF Payout Ratio of 0.98 for Q3 2016, down 26.2% year-over-year from 1.32 in Q4 2015, and up 163.9% quarter-over-quarter from 1.53 in Q2 2016.
Enlivex (ENLV) FCF Payout Ratio (2013 - 2016) Analysis & Trends
Enlivex's FCF Payout Ratio history runs 4 years deep, the most recent figure standing at 0.98 for Q3 2016.
- In Q3 2016, FCF Payout Ratio fell 26.2% year-over-year to 0.98; the TTM figure through Sep 2016 stood at 1.41 (changed 0.17% YoY), while the FY2015 annual figure was 0.55, up 76.85% from the prior year.
- FCF Payout Ratio for Q3 2016 stood at 0.98, up from 1.53 in the prior quarter.
- The five-year high for FCF Payout Ratio was 1.32 in Q3 2015, with the low at 20.78 in Q3 2014.
- The 4-year median for FCF Payout Ratio is 1.75 (2015), against an average of 3.36.
- Peak annual rise in FCF Payout Ratio reached 653.16% in 2014, while the deepest fall reached 1426.54% in 2014.
- Enlivex's FCF Payout Ratio stood at 0.47 in 2013, then plunged by 1426.54% to 7.24 in 2014, then soared by 72.27% to 2.01 in 2015, then jumped by 148.61% to 0.98 in 2016.
- Business Quant data shows ENLV's FCF Payout Ratio at 0.98 in Q3 2016, 1.53 in Q2 2016, and 2.42 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.07 |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 0.98 |
| Jun 30, 2016 | -1.53 |
| Mar 31, 2016 | -2.42 |
| Dec 31, 2015 | -2.01 |
| Sep 30, 2015 | 1.32 |
| Jun 30, 2015 | -0.73 |
| Mar 31, 2015 | -1.98 |
| Dec 31, 2014 | -7.24 |
| Sep 30, 2014 | -20.78 |
| Jun 30, 2014 | 1.12 |
| Mar 31, 2014 | -8.19 |
| Dec 31, 2013 | -0.47 |
| Sep 30, 2013 | -4.91 |
| Jun 30, 2013 | -0.20 |